Zobrazeno 1 - 8
of 8
pro vyhledávání: '"J W J Hans, Bijlsma"'
Autor:
J W J Hans, Bijlsma, J W Annemarie, Hagemeijer, Marc, Bijl, Tim L Th A, Jansen, Mart A F J, van de Laar, Robert B M, Landewé, Mike T, Nurmohamed
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 155(30-31)
A multidisciplinary working group has developed a practice guideline containing various recommendations on the responsible and efficient use of biologicals. These biologicals include both soluble immune-receptor proteins and monoclonal antibodies tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::967004ba3de6d99bdf48a3ab590539ee
https://pubmed.ncbi.nlm.nih.gov/22085508
https://pubmed.ncbi.nlm.nih.gov/22085508
Autor:
Paco M J, Welsing, Marc, Bijl, Ad A, van Bodegraven, Willem F, Lems, Erol, Prens, J W J Hans, Bijlsma
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 155(29)
Where health care is concerned, the introduction of biologicals has greatly improved the treatment of chronic inflammatory disorders. This class of drugs is not only noticeably effective, but is also well tolerated. The cost effectiveness of these dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::01e8b0af3436a4a20ef0c3c3b247587c
https://pubmed.ncbi.nlm.nih.gov/21791128
https://pubmed.ncbi.nlm.nih.gov/21791128
Autor:
Willem F, Lems, J W J Hans, Bijlsma
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 155(29)
It is becoming clearer that early treatment of rheumatoid arthritis (RA) is useful. Recently, Dutch investigators observed a difference between RA referred early (within 12 weeks) and RA referred later (after 12 weeks). Patients who were referred ear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4ad1188cd349af4489c8fac3a06f7822
https://pubmed.ncbi.nlm.nih.gov/21791137
https://pubmed.ncbi.nlm.nih.gov/21791137
Autor:
Willem F, Lems, J W J Hans, Bijlsma
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 154
Polymyalgia rheumatica (PMR) is a chronic inflammatory rheumatic disorder, which predominantly occurs in patients aged 50 years and older. It can be difficult to differentiate PMR from other diseases, for general practitioners as well as for rheumato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f184d8d1f07cd53950dac69e80a379e
https://pubmed.ncbi.nlm.nih.gov/20482925
https://pubmed.ncbi.nlm.nih.gov/20482925
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 153
Influenza vaccination is important in order to limit flu-related morbidity and mortality. This especially applies to immunocompromised patients, such as HIV-infected individuals and patients on immunosuppressive treatment, who have an increased risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c211797bf9fde498e8652860b3c67e30
https://pubmed.ncbi.nlm.nih.gov/19857314
https://pubmed.ncbi.nlm.nih.gov/19857314
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 153
Some accidents due to methotrexate (MTX) have been reported to the Dutch Health Authorities. However, for modern, intensive treatment of patients with rheumatoid arthritis and various other chronic autoimmune diseases, we cannot do without the drug,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a6125c0237157a01862cbdc4454f5528
https://pubmed.ncbi.nlm.nih.gov/19785862
https://pubmed.ncbi.nlm.nih.gov/19785862
Autor:
J W G Hans, Jacobs, Tom W J, Huizinga, J W J Hans, Bijlsma, Annette H M, van der Helm-van Mil
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 153
Thanks to progress in genetic research, various genetic factors involved in the pathogenesis of rheumatoid arthritis (RA) have been discovered.There is a difference in genetic risk factors for RA in patients with or without antibodies against cyclic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::81ba65fc7fe2ae67732286c47f3457d3
https://pubmed.ncbi.nlm.nih.gov/19785838
https://pubmed.ncbi.nlm.nih.gov/19785838
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 153
In a recent equivalence clinical trial, prednisolone was reported to be equally effective as naproxen in the treatment of acute gout arthritis. The authors stated that the study provides a strong argument to consider prednisolone as first-line therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3c8f6bea0ddaee05e1e7270adc9e003a
https://pubmed.ncbi.nlm.nih.gov/19785794
https://pubmed.ncbi.nlm.nih.gov/19785794